机构：[1]Hongqiao International Institute of Medicine, Shanghai Tongren Hospital/ Faculty of Basic Medicine, Chemical Biology Division of Shanghai Universities E-Institutes, Key Laboratory of Cell Differentiation and Apoptosis of the Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China[2]Department of Hematology, Rui Jin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China[3]Department of Hematology, Shanghai First People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200081, China[4]Hongqiao International Institute of Medicine, Shanghai Tongren Hospital/ Faculty of Basic Medicine, Chemical Biology Division of Shanghai Universities E-Institutes, Key Laboratory of Cell Differentiation and Apoptosis of the Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China
第一作者机构：[1]Hongqiao International Institute of Medicine, Shanghai Tongren Hospital/ Faculty of Basic Medicine, Chemical Biology Division of Shanghai Universities E-Institutes, Key Laboratory of Cell Differentiation and Apoptosis of the Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China
通讯作者：
推荐引用方式(GB/T 7714)：
Lei Hu,Yang Li,Zhou Li,et al.Targeting acute myeloid leukemia CD34(+) stem/progenitor cells with small molecule inhibitor MK-8776[J].LEUKEMIA RESEARCH.2018,72:71-73.doi:10.1016/j.leukres.2018.08.003.
APA：
Lei, Hu,Yang, Li,Zhou, Li,Tong, Ying&Wu, Yingli.(2018).Targeting acute myeloid leukemia CD34(+) stem/progenitor cells with small molecule inhibitor MK-8776.LEUKEMIA RESEARCH,72,
MLA：
Lei, Hu,et al."Targeting acute myeloid leukemia CD34(+) stem/progenitor cells with small molecule inhibitor MK-8776".LEUKEMIA RESEARCH 72.(2018):71-73
